Skip to main content

Gynecologic Health Care Screening

  • Chapter
Office Gynecology

Abstract

Unlike many other specialists, gynecologists are in a unique position to affect the health of their patients before a clinical disease takes hold. Approximately 60% of all office visits to general obstetricians/gynecologists are for the purpose of preventive medicine, and 80% of women see their obstetricians/gynecologists regularly for routine examination. One reason for this is that women are introduced to the medical field at a much earlier age than men due to either childbearing or the need for contraception. In addition, women are generally more aware of their bodies than most men.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Papanicolaou GN. New Cancer Diagnosis. Proceedings Third Race Betterment Conference. Battle Creek, Mich: Race Betterment Foundation; 1928:528–534.

    Google Scholar 

  2. Babes A. Diagnostique du cancer uterin par les frottis. Presse Med. 1928;36:451–454.

    Google Scholar 

  3. Papanicolaou GN, Traut HF. The diagnostic value of vaginal smears in carcinoma of the uterus. Am J Obstet Gynecol. 1941;42:193–206.

    Google Scholar 

  4. Ayre JE. Selective cytology smear for diagnosis of cancer. Am J Obstet Gynecol. 1947;53:609–617.

    PubMed  CAS  Google Scholar 

  5. Preventive and screening services. In: Precis III, An Update in Obstetrics and Gynecology. The American College of Obstetricians and Gynecologists; 1986:51–55.

    Google Scholar 

  6. Cochrane AL, Holland WW. Validation of screening procedures. Br Med Bull. 1971;27:38.

    Google Scholar 

  7. Campion MJ, Reid R: Screening for gynecologic cancer. Obstet Gynecol Clin of N Am. 1990;17:695–727.

    CAS  Google Scholar 

  8. Van Der Graaf Y, Vooijs GP, Gaillard HLJ, et al. Screening errors in cervical cytology screening. Acta Cytol. 1987;31:434–438.

    PubMed  Google Scholar 

  9. Fetherston WC. False-negative cytology in invasive cancer of the cervix. Clin Obstet Gynecol. 1983;26: 929–937.

    Article  PubMed  CAS  Google Scholar 

  10. Richard RM, Vaillant HW. Influence of cell collection techniques upon cytological diagnosis. Cancer. 1965;18:1474.

    Article  Google Scholar 

  11. Garite TJ, Feldman MJ. An evaluation of cytologic sampling techniques: a comparative study. Acta Cytol. 1978:22–83.

    Google Scholar 

  12. Taylor, PT, Andersen WA, Barker SR, et al. The screening Papanicolaou smear: contribution of the endocervical brush. Obstet Gynecol. 1987:70–734.

    Google Scholar 

  13. Walton RJ, Blanchet M, Boyes DA, et al. Cervical cancer screening programs (Department of National Health and Welfare Task Force Report). Can Med Assoc J. 1976;114:1003.

    Google Scholar 

  14. Celentano DD, Klassen AC, Weisman CS, Rosenshein NB. Duration of relative protection of screening for cervical cancer. Prey Med. 1989;18:411.

    Article  CAS  Google Scholar 

  15. Boyes DA, Worth AJ, Anderson GH. Experience with cervical screening in British Columbia. Gynecol Oncol. 1981;12:143–155.

    Article  Google Scholar 

  16. IARC Working Group on Evaluation of Cervical Cancer Screening Programs. Screening for squamous cervical cancer: Duration of low risk after negative results of cervical cytology and its implications for screening policies. Br Med J. 1986;293:659–664.

    Article  Google Scholar 

  17. Clark EA, Anderson JW. Does screening by “Pap” smear help prevent cervical cancer? a case-control study. Lancet. 1979;2:1–4.

    Article  Google Scholar 

  18. Paganini-Hill A, Ross RK. Reliability of recall of drug usage and other health-related information. Am J Epidemiol. 1982;16:114–122.

    Google Scholar 

  19. Principles of diagnosis. In: Gusberg SB, Shingleton HM, Deppe G, eds. Female Genital Cancer. New York: Churchill-Livingstone; 1988:197–221.

    Google Scholar 

  20. Richart, RM. Screening techniques for cervical neoplasia. Clinical Obstet Gynecol. 1979;22:701–712.

    Article  CAS  Google Scholar 

  21. National Cancer Institute Workshop. The 1988 Bethesda system for reporting cervical/vaginal cytologic diagnosis. JAMA. 1989;262:931.

    Article  Google Scholar 

  22. Herbst AL. The Bethesda system for cervical/vaginal cytologic diagnosis. Clin Obstet Gynecol. 1992;35:22–27.

    Article  PubMed  CAS  Google Scholar 

  23. Kutman RJ, Malkasian GD, Soldis A, Solomon D. From Papanicolaou to Bethesda: the rationale for a new cytologic classification. Obstet Gynecol. 1991;77:779.

    Google Scholar 

  24. American Cancer Society. Cancer statistics 1991. CA. 1991;41:1.

    Article  Google Scholar 

  25. The Epidemiology of Endometrial Cancer. In: Sciarra JJ, Lurain JR, eds. Gynecology and Obstetrics. Vol. 4, rev. ed. Philadelphia: JB Lippincott; 1991: chap. 13, 1–10.

    Google Scholar 

  26. Zucker PK, Kasdon EJ, Feldstein ML. The validity of Pap smear parameters as predictors of endometrial pathology in menopausal women. Cancer. 1986;58:2258–2263.

    Google Scholar 

  27. Ny ABP, Reagan J, Hawliczek CT, Wentz BW. Significance of endometrial cells in the detection of endometrial carcinoma and its precursors. Acta Cytol. 1974;18:356–361.

    Google Scholar 

  28. Yancey M, Magelssen D, Demaurez A, Lee R. Classification of endometrial cells on cervical cytology. Obstet Gynecol. 1990;76:1000.

    PubMed  CAS  Google Scholar 

  29. An-Foraker SH, Kawada CY, McKinney D. Endometrial aspiration studies on Isaacs cell sampler with cytohistologic correlation. Acta Cytol. 1979;23:303–308.

    PubMed  CAS  Google Scholar 

  30. Koss LG, Schreiber K, Oberlander SG, Moussouris HF, Lesser M. Detection of endometrial carcinoma and hyperplasia in asymptomatic women. Obstet Gynecol. 1984;64:1–11.

    PubMed  CAS  Google Scholar 

  31. Hofmeister FJ. Endometrial biopsy: another look. Am J Obstet Gynecol. 1974;118:773.

    PubMed  CAS  Google Scholar 

  32. Chambers JT, Chambers SK. Endometrial sampling: when? where? why? with what? Clin Obstet Gynecol. 1992;35:28–39.

    Article  PubMed  CAS  Google Scholar 

  33. Kaunitz AM, Masciello A, Ostrowski M, Rovira EZ. Comparison of endometrial biopsy with the endometrial pippelle and vabra aspirator. J Reprod Med. 1988;38:427.

    Google Scholar 

  34. Loffer FD. Hysteroscopy with selective en dometrial sampling compared with D&C for abnormal uterine bleeding: the value of a negative hysteroscopic view. Obstet Gynecol. 1989;73:16.

    PubMed  CAS  Google Scholar 

  35. Gimpelson R, Rappold H. A comparative study between panoramic hysterescopy with directed biopsies and dilatation and curettage. Am J Obstet Gynecol. 1988;158:489.

    PubMed  CAS  Google Scholar 

  36. Carlson JA, Arger P, Thompson S, Carlson EJ. Clinical and pathologic correlation of endometrial cavity fluid detected by ultrasound in the postmenopausal patient. Obstet Gynecol. 1991;77:119.

    PubMed  Google Scholar 

  37. Epithelial Ovarian Cancer. In: Berek JS, Hacker NF, eds. Practical Gynecologic Oncology. Baltimore: Williams and Wilkins; 1989:327–364.

    Google Scholar 

  38. Advanced Epithelial Ovarian Cancer. In: DiSaia PJ, Creasman WT, eds. Clinical Gynecologic Oncology. 3rd ed. St. Louis: C.V. Mosby; 1989:325–416.

    Google Scholar 

  39. Bast RC, Feeney M, et al. Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest. 1981;68:1331.

    Article  PubMed  Google Scholar 

  40. Bast RC, Klug TL, et al. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. NEJM. 1983;309:883.

    Article  PubMed  Google Scholar 

  41. Kabawat SE, Bast RC, Welsh WR, et al. Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid and clear cell types. Am J Clin Pathol. 1983;79:98.

    PubMed  CAS  Google Scholar 

  42. Schwartz PE. Interpretation of CA-125 values. In: Early Diagnosis and Monitoring of Ovarian Cancer. Woodbridge, NJ: Advise and Consent, Inc;1990:7–9.

    Google Scholar 

  43. Curry SL. Early diagnosis and management of a postmenopausal woman with an adnexal mass. In: Early Diagnosis and Monitoring of Ovarian Cancer. Woodbridge, NJ: Advise and Consent, Inc; 1990:3–5.

    Google Scholar 

  44. Cambell S, Bhan V, Royston P, Whitehead MI, Collins WP. Transabdominal ultrasound screening for early ovarian cancer. Br Med J. 1989;299:1363.

    Article  Google Scholar 

  45. Fleischer AC: Transabdominal and transvaginal sonography of ovarian masses. Clin Obstet Gynecol. 1991;34:433.

    Article  PubMed  CAS  Google Scholar 

  46. Herrmann UJ, Locher GW, Goldhirsch A. Sonographic patterns of ovarian tumors: prediction of malignancy. Obstet Gynecol. 1987;69:777.

    PubMed  Google Scholar 

  47. Higgins RV, van Nagell JR, Donaldson ES, et al. Transvaginal sonography as a screening method for ovarian cancer. Gynecol Oncol. 1989;34:402.

    Article  PubMed  CAS  Google Scholar 

  48. DePriest PD, van Nagell JR. Transvaginal ultrasound screening for ovarian cancer. Clin Obstet Gynecol. 1992;35/1:40.

    Article  PubMed  CAS  Google Scholar 

  49. van Nagell JR, dePriest PD, Puls LE, et al. Ovarian cancer screening in asymptomatic postmenopausal women by transvaginal sonography. Cancer. 1991;68:458.

    Article  PubMed  Google Scholar 

  50. Rodriguez MH, Platt LD, Medearis AL, et al. The use of transvaginal sonography for evaluation of postmenopausal ovarian size and morphology. Am J Obstet Gynecol. 1988;159:810.

    PubMed  CAS  Google Scholar 

  51. Sassone AM, Timor-Tritsch IE, Artner A, et al. Transvaginal sonographic characterization of ovarian disease: evaluation of a new scoring system to predict ovarian malignancy. Obstet Gynecol. 1991;78:70.

    PubMed  CAS  Google Scholar 

  52. Orr JW. Evaluation and monitoring of patients at risk of ovarian cancer. In: Early Diagnosis and Monitoring of Ovarian Cancer. Wood-bridge, NJ: Advise and Consent; 1990:17–20.

    Google Scholar 

  53. Baker LH, Chin TDY, Wagner KV. Progress in screening for early breast cancer. J Surg Oncol. 1985;30:96.

    Article  PubMed  CAS  Google Scholar 

  54. Tabar L, Gad A, Holmbery LH, et al. Reduction in mortality from breast cancer after mass screening with mammography. Lancet.1985:829.

    Google Scholar 

  55. Strax P: Results of mass screening for breast cancer in 50,000 examinations. Cancer. 1976;37:30.

    Article  PubMed  CAS  Google Scholar 

  56. Verbeek ALM, Holland R, Sturmans F, et al. Reduction of breast cancer mortality through mass screening with modern mammography. Lancet. 1984:1272.

    Google Scholar 

  57. O’Malley MS, Fletcher SW. Screening for breast cancer with breast self-examination. JAMA. 1987;257:2197.

    Google Scholar 

  58. Winchester DP, Bernstein JR, Paige ML, Christ ML. The Early Detection and Diagnosis of Breast Cancer. American Cancer Society Monograph, 1988.

    Google Scholar 

  59. Gilbertson VA. The earlier detection of breast cancer. Seminar Oncol. 1974;1:87.

    Google Scholar 

  60. Winchester DP, Senor S, Immerman S, et al. A systematic approach to the evaluation and management of breast masses. Cancer. 1983;51:2535.

    Google Scholar 

  61. Russo J, Frederick J, Ownby HE, et al. Predictors of recurrence and survival of patients with breast cancer. Oncol J Club. 1988;1:2.

    Google Scholar 

  62. Baker L: Breast cancer detection demonstration project: five year summary report. CA.1982;32:194.

    PubMed  CAS  Google Scholar 

  63. Moskowitz M. Screening for breast cancer: how effective are our tests? CA. 1983;33:76.

    Google Scholar 

  64. Cooper RA. Mammography. Clin Obstet Gynecol. 1989;32/4:768.

    Article  PubMed  CAS  Google Scholar 

  65. Fox SA, Klos DS, Tsou CV. Underuse of screening mammography by family physicians. Radiology. 1988;166:431.

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Atamdede, F.I., Atamdede, J.W. (1993). Gynecologic Health Care Screening. In: Knaus, J.V., Isaacs, J.H. (eds) Office Gynecology. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-4340-3_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-4340-3_1

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-8740-7

  • Online ISBN: 978-1-4612-4340-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics